COPD
Prieto-Centurion V, Holm KE, Casaburi R, Porszasz J, Basu S, Bracken NE, Gallardo R 3rd, Gonzalez V, Illendula SD, Sandhaus RA, Sullivan JL, Walsh LJ,[...]
Lauria M, Stiehl B, Santhanam A, O'Connell D, Naumann L, McNitt-Gray M, Raldow A, Goldin J, Barjaktarevic I, Low DA. An analysis of the regional[...]
Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Bengtsson T, Rickard K, Sciurba F. Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment[...]
Hansel NN, Woo H, Koehler K, Gassett A, Paulin LM, Alexis N, Putcha N, Lorizio W, Fawzy A, Belz D, Sack C, Barr RG, Martinez[...]
Motahari A, Barr RG, Han MK, Anderson WH, Barjaktarevic I, Bleecker ER, Comellas AP, Cooper CB, Couper DJ, Hansel NN, Kanner RE, Kazerooni EA, Lynch[...]
Park SC, Saiphoklang N, Phillips J, Wilgus ML, Buhr RG, Tashkin DP, Cooper CB, Barjaktarevic I. Three-Month Variability of Commonly Evaluated Biomarkers in Clinically Stable[...]
Tashkin DP. Age of Initiating Smoking: An Independent Predictor of COPD in Later Life. Am J Respir Crit Care Med. 2023 Jul 10. doi: 10.1164/rccm.202307-1146ED.[...]
Anzueto A, Barjaktarevic IZ, Siler TM, Rheault T, Bengtsson T, Rickard K, Sciurba F; ENHANCE investigators. Ensifentrine, a Novel PDE3 and PDE4 Inhibitor for the[...]
Tashkin DP, Barjaktarevic I. Marijuana Use as a Risk Factor for COPD: Not There Yet. Am J Respir Crit Care Med. 2023 Jun 13. doi:[...]
Arjomandi M, Zeng S, Chen J, Bhatt SP, Abtin F, Barjaktarevic I, Barr RG, Bleecker ER, Buhr RG, Criner GJ, Comellas AP, Couper DJ, Curtis[...]